Orphazyme Inc. (ORPH) stock plunged during pre-market trading. Let’s see why?

IMTE Stock

Orphazyme Inc. (NASDAQ: ORPH) stock declined by 10.18% at last close whereas the ORPH stock price fell during the pre-market trading session by 58.18%. Orphazyme is a late-stage pharmaceutical business that is pioneering the use of heat shock proteins to treat uncommon illnesses. What is happening? Following its evaluation of the new drug application for […]

Orphazyme A/S (ORPH) Stock Plummeting After Failure of ORAIALS-01 Trial Announced

Orphazyme A/S (ORPH) stock prices plummeted by 27.77%  after the market opened on May 7th, 2021, bringing the price per share tumbling down to USD$6.12 after the commencing of the trading day. ORAIALS-01 Ends in Failure The company announced on May 7th, 2021 that the ORAIALS-01 pivotal trial of arimoclomol in amyotrophic lateral sclerosis (ALS) […]